Impact of A Nutritional Supplements' Combination (FERTILIS) on Male

Status Recruiting

Clinical Trial Summary

Infertility is a major health problem affecting up to 15% of couples of reproductive age globally. For several years, it was assumed that most reproductive problems could be attributed to the female partner, but research in recent years has demonstrated that males were solely responsible for 20-30% of infertility cases and contributed to 50% of infertility cases overall. The term ''male infertility'' does not constitute a defined clinical syndrome, but rather a collection of different conditions exhibiting a variety of etiologies. It is far increasingly known that reactive oxygen species (ROS) are of significant pathophysiological importance in the etiology of male infertility. ROS are highly reactive oxidizing agents belonging to the class of free radicals containing one or more unpaired electrons, which are continuously being generated through metabolic and pathophysiologic processes. It has been suggested that oxidants interfere with normal sperm function via membrane lipid peroxidation and fragmentation of nucleic acids, which result in sperm dysfunction. Due to the sperm cell membrane abundance of polyunsaturated fatty acids (PUFAs) and the capacity of sperm to generate ROS, human spermatozoa are highly susceptible to oxidative stress. Since growing evidence indicates that oxidative stress can be a primary cause of male infertility, non-enzymatic antioxidants play a significant protective role against oxidative damages and lipid peroxidation. In addition, micronutrients and antioxidants are often used with good results in men with idiopathic infertility. Keeping in view the main protection provided by seminal plasma antioxidants against oxidative damages, a previous study showed that the dietary management with an eight nutritional supplements' combination, similar to this study's product and containing antioxidants, achieved a significant improvement in sperm quality up to a completely normal semen analysis. Also, another study confirmed the hypothesis that the combination of individual nutritional supplements as described in literature showed significantly better results than the sum of the effects of single administration.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04193358
Study type	Interventional
Source	Les Laboratoires des Médicaments Stériles
Contact	Amina Radoui, MSc
Phone	0021698709295
Email	a.radoui@medis.com.tn
Status	Recruiting
Phase	N/A
Start date	February 17, 2020
Completion date	December 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04142112` - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation	N/A
Recruiting	`NCT04955782` - Abstinence Period and Semen Quality
Recruiting	`NCT05506722` - Using of Testes Shocker in Improving the Spermatogenesis and Sperms Activity	N/A
Not yet recruiting	`NCT03988361` - Selection of Non Apoptotic Human Sperm for in Vitro Fertilization by Using Magnetic Activated Cell Sorting (MACS)
Completed	`NCT03319654` - Impact of DNA Fragmentation in Sperm on Pregnancy Outcome After Intra-uterine Insemination in a Spontaneous Cycle	N/A
Not yet recruiting	`NCT05597631` - G-IVF and Sperm Parameters	N/A
Completed	`NCT05919186` - Effects of Antioxidant Supplementation of Culture Media on IVF Embryos	N/A
Recruiting	`NCT03588949` - Role of Nutritional Support in Idiopathic Male Infertility	N/A
Recruiting	`NCT03527043` - Impact of Escitalopram on Sperm DNA Fragmentation	Phase 2
Completed	`NCT02932865` - Modern Analyses of the Semen in Evaluating Male Fertility and Treatment Options of Male Infertility
Completed	`NCT02310087` - Oral Astaxanthin and Semen Quality, Fertilization and Embryo Development in Assisted Reproduction Techniques Procedures	N/A
Completed	`NCT00385346` - Expressive Writing in Male Infertility	N/A
Completed	`NCT04509583` - The Role of Micro Nutrient Supplement in Improvement of the Sperm DNA Fragmentation	N/A
Recruiting	`NCT04144244` - Comparison of the Effect of Microchip and Density Gradient Methods in Intrauterine Insemination Cycles	N/A
Recruiting	`NCT04452305` - Spermatogonial Stem Cell (SSC) Transplant and Testicular Tissue Grafting	N/A
Completed	`NCT05461079` - Sperm Phenotype and Differentially Methylated Regions
Recruiting	`NCT05205733` - Expanding Fertility Care to Poor and Low Resourced Settings Study	N/A
Completed	`NCT03960229` - The Evaluation of the Effect of Microfluidic Sperm Sorting Chip 'Labs-on-a-chip' on IVF Success in Male Factor	N/A
Not yet recruiting	`NCT06050031` - Level of DNA-fragmentation Before and After Antioxidant-based Therapies in Male Infertility
Not yet recruiting	`NCT03090438` - IVF Outcomes After Varicocele Repair	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Impact of A Nutritional Supplements' Combination (FERTILIS) on Male Infertility — FERTILIS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms